Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD-1 Expression in Peripheral Blood T Lymphocytes for Predicting Immune Efficacy in NSCLC
NCT05792995Phase 2Completed
- Start
- Dec 2021
- Primary completion
- Mar 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in non-small cell lung cancer (NSCLC). Started Dec 2021; status: completed.
02
Drugs
sintilimab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05792995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05792995.